Autologous Tissue Regenerating System

For over ten years DERMOAROMA has become known in the world and estimated for the focus turned to constant research and development, able to assert itself in the Italian and International Medical Aesthetics market, with specific products in the field of regenerative medicine.

Latest generation of platelet‐rich plasma

Basing its activities on the developed technologies, the company was able to make distribution agreements with exclusive partners for the commercialization of bio‐technology of the latest generation, or kit devoted to the preparation of platelet‐rich plasma (PRP).

In this particular field Dermoaroma takes the opportunity of a market for the highest level both medically and in terms of commercial potential and future developments, as the products from the cells are now the highest forefront of science and bio‐technology.

Through the high capacity, high technical expertise, reliability and ethical vision of the business, Dermoaroma proves to have a strong base on which to build a qualitative and concrete offer. Thanks to the synergy and experience of professional people, significant results have got through collaboration with the medical profession, working with major Italian universities, and promoting studies and constant analysis on samples of their products to test and certify their validity.

Our mission is to develop advanced chemical research to provide reliable solutions, ready to use, fast and effective in the field of regenerative medicine, of high‐level, offering the most modern and delicate equipment for the production of PRP.

What is PRP?

DPG PRP is blood plasma that has been enriched with platelets

As a concentrated source of autologous platelets, PRP contains (and releases through degranulation) several different growth factors and other cytokines that stimulate the healing of bone and soft tissue.

PRP is a revolutionary method that represents the new frontier for therapeutic cell regeneration, a safe and effective solution that ensures reproducibility and standardization of results.

DPG PRP is a product of new generation, made according to advanced technology, intended to improve the quality and effectiveness of their use. They are all CE‐marked (93/42/EEC updated by Directive 2007/47/CEE) and further validated in accordance with numerous ISO certifications, such as ISO 9001:2008, EN ISO 13485:2012 and EN ISO14971:2009, ISO 10993‐1:2009, ISO 10993‐3:2005 and FDA.

The kits are sterile primary packaging and their packaging is done in an environment with laminar flow, and are certified as a medical device class IIa, registered with the classification CND at the Ministry of Health in the National registration number.